BIOL Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
20%
Last Quarter
- $0.08
Past Year
- $20.50
Growth Past 5yrs
59.5%
Next Quarter
- $0.07
Estimate Next Year
$81.33
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On N/A
Actual EPS vs Estimated EPS
BIOL Earnings Per Share (EPS) History
According to financial reports, BIOL (NYSE: BIOL) reported an actual EPS of $-0.08 for the quarter ending on Aug 08, 2024, compared to an estimated $-0.07, resulting in a 14.29% surprise. In the prior quarter (May 13, 2024), BIOL recorded an actual EPS of $-0.36 with a 111.76% surprise. See BIOL's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIOL has experienced notable EPS surprises, with the latest quarter ending Aug 08, 2024 showing a 14.29% beat. Previously, the quarter ending May 13, 2024 recorded a 111.76% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Aug 08, 2024 | -0.08 | -0.07 | +14.29% |
| May 13, 2024 | -0.36 | -0.17 | +111.76% |
| Mar 21, 2024 | -1.76 | -2.55 | -30.98% |
| Jan 29, 2024 | -1.75718 | -2.55 | -31.09% |
| Nov 09, 2023 | -3.89 | -1.85 | +110.27% |
| Aug 10, 2023 | 8.93 | 5.33 | +67.54% |
Frequently Asked Questions
Is BIOL stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIOL stock an average recommendation of
N/A. 0 analysts have given their ratings
to BIOL out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for BIOL highest price target?
Analysts suggest BIOL's stock price would rise to a high of -.
What is the lowest price target analysts expect for BIOL over the next year?
Within the next 12 months, analysts predict the BIOL stock price could move to -.
What is the average target price for BIOL?
BIOL stock has an average analyst estimate of -.
At its current price, how far is BIOL from its average target price?
BIOL shares are currently trading 0% below this price target.
What were BIOL’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.08 versus consensus estimates of - $0.07, and above the comparable year-ago quarter’s EPS of - $3.89.
What are the current estimates for quarterly and annual earnings per share?
BIOL's forecasts by analysts estimating quarterly EPS at - $0.07 and $81.33 for the whole year.
What has BIOL's growth been in the past five years and what is expected in the next five years?
The analysts have projected 20% EPS growth for BIOL in the next five years, compared to growth rates of 59.5% in the past five years.